RESUMEN
Dysfunction of some mitochondrial aminoacyl-tRNA synthetases (encoded by the KARS1, HARS2, LARS2 and NARS2 genes) results in a great variety of phenotypes ranging from non-syndromic hearing impairment (NSHI) to very complex syndromes, with a predominance of neurological signs. The diversity of roles that are played by these moonlighting enzymes and the fact that most pathogenic variants are missense and affect different domains of these proteins in diverse compound heterozygous combinations make it difficult to establish genotype-phenotype correlations. We used a targeted gene-sequencing panel to investigate the presence of pathogenic variants in those four genes in cohorts of 175 Spanish and 18 Colombian familial cases with non-DFNB1 autosomal recessive NSHI. Disease-associated variants were found in five cases. Five mutations were novel as follows: c.766C>T in KARS1, c.475C>T, c.728A>C and c.1012G>A in HARS2, and c.795A>G in LARS2. We provide audiograms from patients at different ages to document the evolution of the hearing loss, which is mostly prelingual and progresses from moderate/severe to profound, the middle frequencies being more severely affected. No additional clinical sign was observed in any affected subject. Our results confirm the involvement of KARS1 in DFNB89 NSHI, for which until now there was limited evidence.
Asunto(s)
Aminoacil-ARNt Sintetasas , Humanos , Aminoacil-ARNt Sintetasas/genética , Masculino , Femenino , Niño , Preescolar , Adolescente , Pérdida Auditiva/genética , Proteínas Mitocondriales/genética , Adulto , Linaje , Mitocondrias/genética , Mutación , Lactante , Sordera/genética , Fenotipo , Estudios de Asociación Genética , Lisina-ARNt Ligasa/genéticaRESUMEN
OBJECTIVE: To describe the results from the hearing screening protocol adopted in a Hospital in Colombia emphasizing the importance of performing screening on an outpatient basis, when the newborn is more than 24â¯h old. METHODS: A prospective study at Hospital Universitario San Ignacio in Bogota, Colombia was carried out, from May 1st, 2016 to Nov 30th, 2017, the study sample included 2.088 newborns examined using transient otoacoustic emissions. RESULTS: We obtained written consent from the parents of 1.523 newborns and 24 individuals (1.6%) failed the first stage of the screening, nine cases unilateral and 15 bilateral. A total of nine neonates (0,6%) failed the second screening test, six cases unilateral and three bilateral. Four (0,3%) did not return to the second test. Our false altered screening rate was 0.7%. CONCLUSIONS: In a developing country with limited human and economic resources, in which newborn early discharge is the norm, a newborn hearing screening program linked to infants' check-ups, that uses otoacoustic emissions after 48â¯h of life, seems a feasible option compare to the standard US protocol aiming to conduct hearing screening prior to discharge.
Asunto(s)
Países en Desarrollo , Pérdida Auditiva Bilateral/diagnóstico , Pérdida Auditiva Unilateral/diagnóstico , Tamizaje Neonatal/métodos , Atención Ambulatoria , Colombia , Femenino , Pruebas Auditivas , Hospitales , Humanos , Recién Nacido , Masculino , Emisiones Otoacústicas Espontáneas , Estudios ProspectivosRESUMEN
Autosomal recessive nonsyndromic hearing impairment (NSHI) is a heterogeneous condition, for which 53 genetic loci have been reported, and 29 genes have been identified to date. One of these, OTOF, encodes otoferlin, a membrane-anchored calcium-binding protein that plays a role in the exocytosis of synaptic vesicles at the auditory inner hair cell ribbon synapse. We have investigated the prevalence and spectrum of deafness-causing mutations in the OTOF gene. Cohorts of 708 Spanish, 83 Colombian, and 30 Argentinean unrelated subjects with autosomal recessive NSHI were screened for the common p.Gln829X mutation. In compound heterozygotes, the second mutant allele was identified by DNA sequencing. In total, 23 Spanish, two Colombian and two Argentinean subjects were shown to carry two mutant alleles of OTOF. Of these, one Colombian and 13 Spanish subjects presented with auditory neuropathy. In addition, a cohort of 20 unrelated subjects with a diagnosis of auditory neuropathy, from several countries, was screened for mutations in OTOF by DNA sequencing. A total of 11 of these subjects were shown to carry two mutant alleles of OTOF. In total, 18 pathogenic and four neutral novel alleles of the OTOF gene were identified. Haplotype analysis for markers close to OTOF suggests a common founder for the novel c.2905_2923delinsCTCCGAGCGCA mutation, frequently found in Argentina. Our results confirm that mutation of the OTOF gene correlates with a phenotype of prelingual, profound NSHI, and indicate that OTOF mutations are a major cause of inherited auditory neuropathy.
Asunto(s)
Pérdida Auditiva Sensorineural/genética , Proteínas de la Membrana/genética , Argentina , Colombia , Femenino , Genes Recesivos , Humanos , Masculino , Mutación , EspañaRESUMEN
Introducción: Las pérdidas auditivas son heredables en un 50-60% de los casos. Dentro de estas, las sorderas no sindrómicas predominan y se han descrito más de 40 genes asociados. Uno de los más frecuentemente implicados es el gen de Otoferlina(OTO F). Objetivo: Determinar la frecuencia de la mutación p.Q829X en el gen OTO F en 649 individuos colombianos con sordera no sindrómica. Materiales y métodos: Se seleccionó una población de 649 individuos para realizar la búsqueda de la mutación p.Q829X por medio de la técnica PCR-RFLP. Resultados: Se identificaron 12 individuos con la mutación p.Q829X (12/649), quecorresponden a una frecuencia del 1,8%. Conclusiones: La mutación p.Q829X es la más frecuente en el gen OTO F, y la tercera luego de las mutaciones S199F y 35delG en el gen GJB2, causantes de sordera en la población analizada. Se observó variabilidad en el grado de pérdida auditiva en los individuos homocigotos para la mutación y presencia deneuropatía auditiva en el 62,5% de estos casos...
Introduction: Hearing loss is 50-60 % heritable. Among this, non-syndromic hearing loss is predominant and more than 40 genes have been reported. One of the most frequently involved is OTO F gene. Objective: To identify the frequency of mutation p.Q829X in OTO F gene, in 649 Colombian individuals with non-syndromic deafness. Materials and Methods: A total of 649 individuals were selected and screened for p.Q829X mutation using PCR-RFLP analysis. Results: p.Q829X mutation was identified in 12 deaf individuals (12/649) corresponding to a frequencyof 1,8%. Conclusions: p.Q829X mutation is the most common in OTO F gene, and the third cause after S199F and 35delG mutations in GJB2 gene, ofdeafness in the analyzed population. Variability is observed in the degree of hearing loss in individuals homozygous for the mutation and auditoryneuropathy is present in 62,5% of these cases...